In addition, we and others reported that LON in lymphoma and rheumatic patients is related to the possession of certain BAFF and FCGR3 gene polymorphisms [13, 14], suggesting possible gene-drug interactions. This evidence concerns the gene TNFSF13B and lymphoma.